Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M597Revenue $M16.9Net Margin (%)-73.2Z-Score1.0
Enterprise Value $M603EPS $-1.2Operating Margin %-55.7F-Score5
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-73.2Higher ROA y-yY
Price/Book33.610-y EBITDA Growth Rate %-60.4Quick Ratio4.4Cash flow > EarningsY
Price/Sales9.45-y EBITDA Growth Rate %14.1Current Ratio4.8Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-40.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-180.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M62.7ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with RPTP

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RPTPJoel Greenblatt 2014-09-30 Buy $8.09 - $11.54
($10.22)
$ 9.4-8%New holding, 22595 sh.22,595
RPTPJean-Marie Eveillard 2007-06-30 Sold Out $105.78 - $127.38
($117.35)
$ 9.4-92%Sold Out0
RPTPGeorge Soros 2006-03-31 Sold Out $15.14 - $19.73
($17.01)
$ 9.4-45%Sold Out0
RPTPGeorge Soros 2005-09-30 Buy $19.22 - $24.66
($22.11)
$ 9.4-58%New holding, 47700 sh.47,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RPTP is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
RPTP Joel Greenblatt 2014-09-3022,5950.040New Buy
Premium Most recent portfolio changes are included for Premium Members only!


RPTP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STARR CHRISTOPHER MCEO 2014-11-17Sell30,000$9.91-1.01view
STARR CHRISTOPHER MCEO 2014-10-22Sell30,000$10.25-4.29view
STARR CHRISTOPHER MCEO 2014-10-15Sell30,000$10.04-2.29view
STARR CHRISTOPHER MCEO 2014-09-23Sell30,000$10.21-3.92view
STARR CHRISTOPHER MCEO 2014-09-16Sell32,896$10.6-7.45view
Anderson RaymondDirector 2014-09-10Sell10,000$10.81-9.25view
SAGER ERICHDirector 2014-08-25Sell10,000$11.01-10.9view
Anderson RaymondDirector 2014-07-07Sell27,500$11.21-12.49view
Keltner LlewDirector 2014-07-07Sell10,000$11.21-12.49view
Keltner LlewDirector 2014-05-30Buy100$8.3717.2view

Press Releases about RPTP :

    Quarterly/Annual Reports about RPTP:

    News about RPTP:

    Articles On GuruFocus.com
    comment on RPTP Mar 15 2013 

    More From Other Websites
    Raptor Pharmaceutical to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 18 2014
    RAPTOR PHARMACEUTICAL CORP Financials Nov 14 2014
    10-Q for Raptor Pharmaceutical Corp. Nov 08 2014
    Raptor Pharmaceutical tops Street 3Q forecasts Nov 06 2014
    Raptor Pharmaceutical tops Street 3Q forecasts Nov 06 2014
    Raptor Pharmaceutical Reports Third Quarter 2014 Financial Results and Provides Corporate Update Nov 06 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 06 2014
    Raptor Pharmaceutical Reports Third Quarter 2014 Financial Results and Provides Corporate Update Nov 06 2014
    Q3 2014 Raptor Pharmaceutical Corp Earnings Release - After Market Close Nov 06 2014
    Raptor Pharmaceutical to Hold Third Quarter 2014 Financial Results Conference Call and Webcast on... Oct 29 2014
    Raptor Pharmaceutical to Hold Third Quarter 2014 Financial Results Conference Call and Webcast on... Oct 29 2014
    CFO Moves: NewMarket Corp., Pearson PLC Oct 24 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other... Oct 24 2014
    Raptor Pharmaceutical Announces Management Changes Oct 23 2014
    Raptor Pharmaceutical Announces Management Changes Oct 23 2014
    Raptor Pharmaceuticals (RPTP) Crumbles: Stock Falls by 7.2% Sep 30 2014
    Raptor Pharmaceutical to Present at Leerink Rare Disease Roundtable Sep 23 2014
    Raptor Pharmaceutical to Present at Upcoming Investor Conference in September Aug 27 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Aug 21 2014
    Raptor Pharmaceuticals (RPTP) Jumps: Stock Adds 28.2% in Session Aug 11 2014
    Why Raptor Pharmaceuticals (RPTP) Stock Is Gaining Today Aug 08 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition Aug 07 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Other Events Aug 05 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission... Aug 04 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers Jul 29 2014
    Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic Jul 24 2014
    Raptor Pharmaceutical to Hold First Quarter 2014 Financial Results Webcast and Conference Call Apr 30 2014
    Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2013 Financial Results and Provides... Mar 13 2014
    Raptor Pharmaceutical to Hold Fourth Quarter and Full Year 2013 Financial Results Webcast and... Mar 10 2014
    Raptor Pharmaceutical to Present at Two Upcoming Investor Conferences Feb 24 2014
    Raptor Announces Clinical Results With RP103 in Huntington's Disease Phase 2/3 Trial Feb 20 2014
    Raptor Announces Full Enrollment of Phase 2b Trial of RP103 for Non-Alcoholic Fatty Liver Disease in... Jan 13 2014
    Raptor Submits IND for RP103 for Leigh Syndrome and Other Mitochondrial Disorders Dec 10 2013

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK